Ethical considerations in standardized letters of evaluation for dermatology residency selection.
Alkiswani H, Shaikh UR, Richter CG, Raj LK, Higgins HW, Grant-Kels JM
Clinics in DermatologyIn the feed 30 Aug 2026, published online 30 Aug 2026, issue 2026 Aug 30, added to PubMed 30 Aug 2026
Topics: Practice, education & research
Abstract
The introduction of dermatology's specialty-specific standardized letter of evaluation for the 2026-2027 residency cycle aims to improve fairness and comparability and reduce bias in applicant assessment. Although standardization may reduce differences in writing style and interpretation, it does not eliminate subjectivity and may shift how and where bias affects the process. Rating inflation, ceiling effects, and interrater variability have been reported in dermatology and other specialties, yet evidence that standardized ratings predict residency performance remains limited. In addition, standardizing evaluation does not standardize opportunity: ratings of research, professionalism, and communication may reflect differences in mentorship, resources, clinical exposure, and evaluator relationships. Programs should therefore avoid interpreting small numerical differences as precise measures of ability and instead treat standardized letters of evaluation as part of a holistic review. Ethical implementation will require ongoing assessment of rating inflation, interrater variability, demographic disparities, and predictive validity. Ultimately, the standardized letter of evaluation's value will depend on whether it improves comparability and transparency without creating false precision or masking unequal opportunities.
Abstract from PubMed
PMID 42669316 · DOI 10.1016/j.clindermatol.2026.08.015